Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment

Authors

Jonathan I. Silverberg, George Washington University School of Medicine, Washington, DC, USA. jonathanisilverberg@gmail.com.
Andreas Wollenberg, Department of Dermatology and Allergy, University Hospital Augsburg, Augsburg, Germany.
Linda Stein Gold, Henry Ford Health System, Detroit, MI, USA.
James Del Rosso, JDR Dermatology Research, Las Vegas, NV, USA.
Gil Yosipovitch, Miller School of Medicine, University of Miami, Miami, FL, USA.
Peter Lio, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Jose-Manuel Carrascosa, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, IGTP, Barcelona, Spain.
Gaia Gallo, Eli Lilly and Company, Indianapolis, IN, USA.
Yuxin Ding, Eli Lilly and Company, Indianapolis, IN, USA.
Zhenhui Xu, CIMS Global LLC, Somerset, NJ, USA.
Marta Casillas, Eli Lilly and Company, Indianapolis, IN, USA.
Evangeline Pierce, Eli Lilly and Company, Indianapolis, IN, USA.
Helena Agell, Almirall S.A., Barcelona, Spain.
Sonja Ständer, Center for Chronic Pruritus and Department of Dermatology, University Hospital Münster, Münster, Germany.

Document Type

Journal Article

Publication Date

10-18-2024

Journal

Dermatology and therapy

DOI

10.1007/s13555-024-01269-y

APA Citation

Silverberg, Jonathan I.; Wollenberg, Andreas; Stein Gold, Linda; Del Rosso, James; Yosipovitch, Gil; Lio, Peter; Carrascosa, Jose-Manuel; Gallo, Gaia; Ding, Yuxin; Xu, Zhenhui; Casillas, Marta; Pierce, Evangeline; Agell, Helena; and Ständer, Sonja, "Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment" (2024). GW Authored Works. Paper 5810.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/5810

Department

Dermatology